+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893115
Description Jump to:
The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.

Respiratory Disease Testing Market Report Highlights

  • Growing prevalence of respiratory diseases and rapid technological advancements are two of the major factors expected to propel the market growth
  • Based on products, imaging tests held the largest share in 2022 due to rapid development and adoption of innovative technologies
  • Based on application, tuberculosis was the largest market in 2022 owing to rising prevalence of the disease globally
  • Based on end-use, hospitals segment held the largest share in 2022 and is anticipated to grow over the forecast period due to an increase in hospitalization and a growing preference for hospital treatment
  • North America dominated the respiratory disease testing market in 2022. Growing prevalence of respiratory diseases such as COPD, & asthma, increasing demand for early diagnosis, and rising awareness amongst patients about the benefits of early diagnosis are responsible for the dominance
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as improving healthcare infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma
  • Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Respiratory Disease Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Respiratory Disease Testing Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Respiratory Disease Testing: Product Estimates & Trend Analysis
4.1. Respiratory Disease Testing Market: Key Takeaways
4.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Imaging Tests
4.3.1. Imaging tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Respiratory Measurement devices
4.4.1. Respiratory measurement devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Blood Gas Test
4.5.1. Blood gas test market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Respiratory Disease Testing: Application Estimates & Trend Analysis
5.1. Respiratory Disease Testing Market: Key Takeaways
5.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Chronic Obstructive Pulmonary Disease
5.3.1. Chronic obstructive pulmonary disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Lung Cancer
5.4.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Asthma
5.5.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Tuberculosis
5.6.1. Tuberculosis market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Respiratory Disease Testing: End-use Estimates & Trend Analysis
6.1. Respiratory Disease Testing Market: Key Takeaways
6.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospital
6.3.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Physicians Clinic
6.4.1. Physician clinic market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Clinical Laboratories
6.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Respiratory Disease Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Respiratory Disease Testing Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Abbott
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. BD
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Koninklijke Philips N.V.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. ResMed
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Fisher & Paykel Appliances Ltd
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. BIOMÉRIEUX
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Carestream Health
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. SDI Diagnostics
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Siemens Healthcare GmbH
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 3 North America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 4 North America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 10 Canada respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 11 Canada respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 13 Europe respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 14 Europe respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe respiratory disease testing market, by region, 2018 - 2030 (USD Million)
Table 16 Germany respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 17 Germany respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 18 Germany respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 20 UK respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 21 UK respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 22 France respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 23 France respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 24 France respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 26 Italy respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 27 Italy respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 29 Spain respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 30 Spain respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 31 Sweden respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 32 Sweden respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Norway respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 35 Norway respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 36 Norway respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 37 Denmark respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 38 Denmark respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 39 Denmark respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 41 Asia Pacific respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific respiratory disease testing market, by region, 2018 - 2030 (USD Million)
Table 44 Japan respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 45 Japan respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 46 Japan respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 47 China respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 48 China respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 49 China respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 50 India respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 51 India respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 52 India respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 53 Thailand respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 54 Thailand respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 55 Thailand respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Australia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 60 Australia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 61 Australia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 63 Latin America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa respiratory disease testing market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 86 UAE respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 87 UAE respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait respiratory disease testing market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait respiratory disease testing market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Respiratory disease testing: Market outlook
Fig. 9 Respiratory disease testing: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Respiratory disease testing market driver impact
Fig. 15 Respiratory disease testing market restraint impact
Fig. 16 Respiratory disease testing market strategic initiatives analysis
Fig. 17 Respiratory disease testing market: Product movement analysis
Fig. 18 Respiratory disease testing market: Product outlook and key takeaways
Fig. 19 Imaging tests market estimates and forecasts, 2018 - 2030
Fig. 20 Respiratory measurement devices market estimates and forecasts, 2018 - 2030
Fig. 21 Blood gas test market estimates and forecasts, 2018 - 2030
Fig. 22 Others market estimates and forecasts, 2018 - 2030
Fig. 23 Respiratory disease testing market: Application movement analysis
Fig. 24 Respiratory disease testing market: Application outlook and key takeaways
Fig. 25 Chronic obstructive pulmonary disease market estimates and forecasts, 2018 - 2030
Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030
Fig. 27 Asthma market estimates and forecasts, 2018 - 2030
Fig. 28 Tuberculosis market estimates and forecasts, 2018 - 2030
Fig. 29 Others market estimates and forecasts, 2018 - 2030
Fig. 30 Respiratory disease testing market: End-use movement analysis
Fig. 31 Respiratory disease testing market: End-use outlook and key takeaways
Fig. 32 Hospital market estimates and forecasts, 2018 - 2030
Fig. 33 Physicians clinic market estimates and forecasts, 2018 - 2030
Fig. 34 Clinical laboratories market estimates and forecasts, 2018 - 2030
Fig. 35 Others market estimates and forecasts, 2018 - 2030
Fig. 36 Global Respiratory Disease Testing Market: Regional Movement Analysis
Fig. 37 Global Respiratory disease testing market: Regional outlook and key takeaways
Fig. 38 North America market estimates and forecasts, 2018 - 2030
Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
Fig. 40 Canada market estimates and forecasts, 2018 - 2030
Fig. 41 Europe market estimates and forecasts, 2018 - 2030
Fig. 42 UK market estimates and forecasts, 2018 - 2030
Fig. 43 Germany market estimates and forecasts, 2018 - 2030
Fig. 44 France market estimates and forecasts, 2018 - 2030
Fig. 45 Italy market estimates and forecasts, 2018 - 2030
Fig. 46 Spain market estimates and forecasts, 2018 - 2030
Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
Fig. 48 Norway market estimates and forecasts, 2018 - 2030
Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 51 Japan market estimates and forecasts, 2018 - 2030
Fig. 52 China market estimates and forecasts, 2018 - 2030
Fig. 53 India market estimates and forecasts, 2018 - 2030
Fig. 54 Australia market estimates and forecasts, 2018 - 2030
Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
Fig. 59 Mexico market estimates and forecasts, 2018 - 2030
Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
Fig. 64 UAE market estimates and forecasts, 2018 - 2030
Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • Abbott
  • BD
  • Koninklijke Philips N.V.
  • ResMed
  • Fisher & Paykel Appliances Ltd
  • Medtronic
  • BIOMÉRIEUX
  • Carestream Health
  • SDI Diagnostics
  • Siemens Healthcare GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 6.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.75 Billion
Compound Annual Growth Rate2.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Respiratory Disease Testing Market by Product, End-Use - Global Forecast 2025-2030 - Product Image

Respiratory Disease Testing Market by Product, End-Use - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Respiratory Disease Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Respiratory Disease Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Respiratory Disease Testing - Global Strategic Business Report - Product Image

Respiratory Disease Testing - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Respiratory Disease Testing Global Market Report 2024 - Product Image

Respiratory Disease Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Respiratory Disease Testing Market Analysis & Forecast to 2024-2034 - Product Image

Respiratory Disease Testing Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.